Daniel Joseph Apel serves as Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Daniel Joseph Apel has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 6, 2026 involved receiving (via award) 75,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 6, 2026 | ARWR | $0 | Award | 75,000 | $N/A | Discretionary |
Daniel Joseph Apel currently holds 176,200 shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Daniel Joseph Apel has been a net neutral trader of ARWR stock. They have purchased $0 and sold $0 worth of shares.
Daniel Joseph Apel's most recent insider trade was on Jan 6, 2026, when they sold 75,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted